Envoy Medical (COCHW) Non-Current Deffered Revenue (2021 - 2023)

Envoy Medical's Non-Current Deffered Revenue history runs 3 years deep, the most recent figure standing at $10.4 million for Q2 2023.

• In Q2 2023, Non-Current Deffered Revenue fell 30.0% year-over-year to $10.4 million; the TTM figure through Jun 2023 stood at $10.4 million (down 30.0% YoY), while the FY2022 annual figure was $10.4 million, down 30.0% from the prior year.
• Non-Current Deffered Revenue came in at $10.4 million for Q2 2023 at Envoy Medical, roughly flat from $10.4 million in the prior quarter.
• In the past five years, Non-Current Deffered Revenue ranged from a high of $14.9 million in Q2 2021 to a low of $10.4 million in Q3 2022.
• A 3-year average of $13.1 million and a median of $14.8 million in 2021 frame the typical range for Non-Current Deffered Revenue.
• On a YoY basis, Non-Current Deffered Revenue climbed as much as 1.19% in 2022 and fell as far as 30.0% in 2022.
• Envoy Medical's Non-Current Deffered Revenue stood at $14.9 million in 2021, then declined by 30.0% to $10.4 million in 2022, then changed by 0.0% to $10.4 million in 2023.
• According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $10.4 million, $10.4 million, and $10.4 million for Q2 2023, Q1 2023, and Q4 2022 respectively.

Peer Comparison